| scholarly article | Q13442814 |
| P2093 | author name string | Ning Wang | |
| Bin Shi | |||
| Ping Fan | |||
| Ru Jia | |||
| Fang-Fang Xu | |||
| An-Jiao Wang | |||
| Cai-Ping Xiang | |||
| Chun-Hong Yan | |||
| Se-Qing Ma | |||
| P2860 | cites work | Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases | Q24601963 |
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Multidrug resistance in cancer: role of ATP-dependent transporters | Q28208049 | ||
| Histone deacetylase inhibitors regulate P-gp expression in colorectal cancer via transcriptional activation and mRNA stabilization | Q28468630 | ||
| Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. | Q33775085 | ||
| A family of drug transporters: the multidrug resistance-associated proteins. | Q34004952 | ||
| The human ATP-binding cassette (ABC) transporter superfamily. | Q34083168 | ||
| Multidrug resistance: molecular mechanisms and clinical relevance | Q34436952 | ||
| Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance | Q35542125 | ||
| The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver | Q36053511 | ||
| Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines | Q36247606 | ||
| Transport of glutathione and glutathione conjugates by MRP1. | Q36527103 | ||
| Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas. | Q36660672 | ||
| HDAC family: What are the cancer relevant targets? | Q37281991 | ||
| Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapy | Q37665488 | ||
| ABCG2 confers promotion in gastric cancer through modulating downstream CRKL in vitro combining with biostatistics mining | Q37706336 | ||
| The P-glycoprotein multidrug transporter. | Q37941756 | ||
| ABC transporters and their role in nucleoside and nucleotide drug resistance | Q37979617 | ||
| HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters (Review) | Q38333926 | ||
| HDAC inhibitors downregulate MRP2 expression in multidrug resistant cancer cells: implication for chemosensitization | Q39618131 | ||
| Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance | Q39805970 | ||
| Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model | Q40008116 | ||
| The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells | Q40098928 | ||
| Up-regulation of MDR1 and induction of doxorubicin resistance by histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells | Q40381466 | ||
| Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines | Q40434292 | ||
| Twist1 confers multidrug resistance in colon cancer through upregulation of ATP-binding cassette transporters | Q41592959 | ||
| Role of multidrug resistance protein 1 (MRP1) and glutathione S-transferase A1-1 in alkylating agent resistance. Kinetics of glutathione conjugate formation and efflux govern differential cellular sensitivity to chlorambucil versus melphalan toxicit | Q43511881 | ||
| Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells | Q46579453 | ||
| Histone deacetylase inhibitor apicidin-mediated drug resistance: involvement of P-glycoprotein | Q46753140 | ||
| Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176). | Q46988409 | ||
| MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells. | Q47165781 | ||
| Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia | Q47216949 | ||
| Histone deacetylase inhibitors upregulate Snail via Smad2/3 phosphorylation and stabilization of Snail to promote metastasis of hepatoma cells | Q50151814 | ||
| The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia. | Q52691495 | ||
| Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression. | Q54279180 | ||
| Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance | Q64386850 | ||
| P433 | issue | 5 | |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 148 | |
| P577 | publication date | 2020-08-24 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Effect of sodium butyrate on ABC transporters in lung cancer A549 and colorectal cancer HCT116 cells | |
| P478 | volume | 20 |
Search more.